• Investment to Support Technology Roll-Out

News & Views

Investment to Support Technology Roll-Out

Jan 31 2018

Biomanufacturing company Univercells SA, (Gosselies, Belgium) has announced the successful closing of a €3 million ($3.56M) increase in a Series-A equity financing round, led by private investors from Europe and the US.

The capital injection will help enable the commercial introduction of the company’s viral micro-facility, with a first technology transfer anticipated for Q4 2018 within the framework of the Bill & Melinda Gates Foundation-supported program; it will also benefit the company’s recombinant platform development, both of which are aimed at providing a sufficient supply of high-quality biologics at an affordable price.

“We are very proud of this funding round and thankful for this wealth of support,” commented Hugues Bultot, co-founder and CEO of Univercells. “This successful capital increase is a real recognition of the work achieved so far, the innovative technology being developed and the clear expectations and roadmap set. It is highly encouraging to have seasoned industry experts demonstrate such tremendous confidence in Univercells, its ability to transform the industry with their willingness to contribute to our mission.”


Digital Edition

LMUK 49.7 Nov 2024

November 2024

News - Research & Events News   - News & Views Articles - They’re burning the labs... Spotlight Features - Incubators, Freezers & Cooling Equipment - Pumps, Valves & Liquid Hand...

View all digital editions

Events

MEDICA 2024

Nov 11 2024 Dusseldorf, Germany

FILTECH

Nov 12 2024 Cologne, Germany

Intech

Nov 12 2024 Tel Aviv, Israel

analytica China

Nov 18 2024 Shanghai, China

Pharma Asia

Nov 20 2024 Karachi, Pakistan

View all events